Topoisomerase IIα Cleavage Complex Trapping and Double-Strand Break Dynamics
Doxorubicin, an anthracycline antineoplastic agent, functions primarily through the stabilization of the covalent Topoisomerase IIα (Topo IIα)-DNA cleavage complex, effectively halting the catalytic cycle during DNA replication and transcription [1][2]. Intercalation of the planar anthraquinone chromophore between adjacent base pairs at 5'-pyr-pur-3' dinucleotide sequences alters local DNA topology and stabilizes the transient topoisomerase-DNA intermediate [2][3]. When progressing replication forks and RNA polymerase complexes collide with these immobilized ternary adducts, reversible single- and double-strand nicks are converted into permanent, lethal double-strand breaks (DSBs) [1][4].
Cellular responses to doxorubicin exposure feature rapid induction of phosphorylation of histone variant H2AX at Ser139 (γ-H2AX), an early diagnostic marker of severe genomic lesion generation [1][2]. In human breast adenocarcinoma MCF-7 and triple-negative MDA-MB-231 models, γ-H2AX foci accumulate in a strict concentration- and time-dependent manner within 4 to 12 hours of exposure [2]. Similarly, in human mesenchymal progenitor lines and soft-tissue sarcoma models such as HT1080, doxorubicin prompts marked γ-H2AX accrual and early precursor rRNA45S transcription arrest before overt reactive oxygen species (ROS) or direct executioner caspase cleavage occurs [1][2]. Persistent DSBs overwhelm classical non-homologous end joining (NHEJ) and homologous recombination (HR) machinery, promoting extensive chromosomal structural aberrations and nuclear DNA leakage [1][2]. Benchmark kinetic and pharmacological parameters for doxorubicin against reference agents are detailed in Table 1.
Chromosomal Missegregation, Anaphase Lagging, and Micronuclear Biogenesis
Persistent DSBs induced by doxorubicin severely impair faithful chromosome segregation during mitotic transit [3][5]. Cells harboring extensive DNA lesions frequently bypass or slip through the G2/M DNA damage checkpoint due to incomplete ATR/ATM signaling execution or defective centrosome amplification dynamics [5]. During subsequent anaphase, acentric chromosome fragments—generated by Topo IIα-mediated clastogenic cleavage—fail to attach to mitotic spindle microtubules via kinetochores [3][5]. Concurrently, dicentric chromosomes formed through illegitimate repair attempts yield persistent chromatin bridges across the division plane [3].
Fluorescence in situ hybridization (FISH) analyses demonstrate that doxorubicin-induced micronuclei (MN) predominantly lack centromeric signals (C-MN), confirming that these structures arise through clastogenic chromosome fragmentation rather than aneugenic whole-chromosome nondisjunction [3]. As the primary daughter nuclei reform during telophase, lagging acentric fragments are excluded from the main chromatin mass and recruit their own nuclear envelopes from the endoplasmic reticulum, giving rise to secondary, physically isolated micronuclei [3][4].
These aberrant micronuclei possess profound structural pathologies [4][5]. The micronuclear envelope exhibits severe deficits in nuclear pore complex (NPC) density, leading to impaired nucleocytoplasmic transport and unequal distribution of nuclear structural proteins [4]. Critically, the inner nuclear membrane underlying these micronuclei displays discontinuous, highly defective lamin B1 (LMNB1) scaffolds [4]. This structural deficiency leaves the enclosed chromatin vulnerable to mechanical shear forces generated by the surrounding cytoskeleton, setting the stage for membrane breakdown [4][5].
Micronuclear Envelope Rupture and Cytoplasmic Chromatin Exposure
The discontinuous nuclear lamina of doxorubicin-generated micronuclei renders them structurally unstable [4][5]. During cellular migration or normal interphase cytoplasmic remodeling, mechanical compression exerted by the cytoplasmic actomyosin cytoskeleton causes spontaneous rupture of the fragile micronuclear envelope [4]. This physical collapse results in the sudden, irreversible compartmental mixing of micronuclear contents with the cytosol [1][4].
Envelope rupture triggers rapid nuclear DNA leakage, directly exposing high-molecular-weight double-stranded DNA (dsDNA) to the cytosolic environment [1][2]. In MDA-MB-231 and HT1080 cells, 4D fluorescence microscopy demonstrates distinct DAPI-positive, extra-nuclear chromatin fragments accumulating in the cytoplasm within 24 to 48 hours post-treatment [1][2]. Concomitantly, cellular quality-control programs such as selective nucleophagy are engaged, evidenced by microtubule-associated protein 1A/1B-light chain 3B (LC3B-II) lipidation and autophagic flux activation aimed at degrading damaged nuclear fragments [2].
Under physiological homeostasis, cell-autonomous cytoplasmic nucleases, particularly three-prime repair exonuclease 1 (TREX1), degrade misplaced cytosolic DNA to prevent inappropriate immune receptor activation [4][6]. However, following doxorubicin exposure, the magnitude of chromatin released from ruptured micronuclei rapidly exhausts endogenous TREX1 catalytic capacity [1][4]. In addition, mitochondrial stress and altered endosomal trafficking induced by anthracyclines further strain lysosomal and autophagic clearance systems, leaving bulky, naked genomic DNA complexes stable within the cytoplasm [6].
cGAS Condensation, 2'3'-cGAMP Generation, and Downstream STING Translocation
Cytoplasmic exposure of genomic dsDNA resulting from micronuclear rupture triggers recognition by cyclic GMP-AMP synthase (cGAS) [1][4]. Acting as a sequence-independent cytosolic DNA sensor, cGAS binds directly to the sugar-phosphate backbone of double-stranded DNA via multivalent electrostatic interactions [4][5]. When DNA fragment lengths exceed 45 base pairs, binding induces liquid-liquid phase separation, assembling cGAS and dsDNA into dense catalytic micro-droplets [4]. Within these liquid condensates, cGAS undergoes allosteric activation, catalyzing the condensation of adenosine triphosphate (ATP) and guanosine triphosphate (GTP) into the non-canonical second messenger 2'3'-cyclic GMP-AMP (2'3'-cGAMP) [1][4].
Generated 2'3'-cGAMP rapidly diffuses through the cytosol to bind stimulator of interferon genes (STING, encoded by STING1), an endoplasmic reticulum (ER)-resident transmembrane adaptor protein [1][4]. Ligand engagement prompts a 180° rotation of the STING cytoplasmic domain, closing the ligand-binding pocket and driving STING homodimerization and higher-order oligomerization [1]. Activated STING complexes undergo post-translational palmitoylation at residues Cys88 and Cys91 within the ER, a critical step for loading into coatomer protein complex II (COPII) vesicles for translocation to the Golgi apparatus [1][4].
At the Golgi apparatus, oligomerized STING recruits TANK-binding kinase 1 (TBK1), promoting its autophosphorylation at Ser172 [1][4]. Phosphorylated TBK1 then phosphorylates the C-terminal tail of STING, generating a docking site for interferon regulatory factor 3 (IRF3) [1]. TBK1-mediated phosphorylation of IRF3 drives IRF3 dimerization, nuclear translocation, and transcriptional activation of Type I interferon genes, prominently including IFNB1, alongside critical chemokines such as CXCL10 and CCL5 [1][5]. Genetic ablation of STING1 via CRISPR-Cas9 completely abolishes doxorubicin-mediated induction of Ccl5, Cxcl10, and Ifnb1 in soft-tissue sarcoma models (such as mouse CCRF S-180 II and WEHI-164), proving that cytosolic DNA sensing is obligatory for anthracycline-induced immune signaling [1].
Immunogenic Profile: Distinguishing Senescence Signaling from Apoptosis
The immunological consequences of doxorubicin-mediated DNA damage are governed by exposure concentration and duration, establishing a bifurcation between pro-inflammatory senescence and immunologically silent or suppressive apoptosis [1][7]. In human cardiac progenitor lines and soft-tissue sarcomas, high-dose doxorubicin (exceeding 1 µM continuously) drives severe cytotoxicity and activates executioner caspases, predominantly Caspase-3 (CASP3) and Caspase-7 (CASP7), within 24 to 48 hours [1][7]. Activated CASP3 directly cleaves cGAS, STING, and IRF3, effectively quenching innate immune sensing and preventing Type I interferon induction despite abundant DNA breaks [1]. Concurrently, caspase-activated DNase (CAD) mediates uniform nucleosomal laddering, producing DNA fragments that are poor substrates for cGAS phase separation [4][7].
Conversely, sub-micromolar pulsed regimens (50 to 150 nM) or transient exposures favor cell cycle exit into a prolonged, stable senescence-associated secretory phenotype (SASP) without triggering immediate cell death [1][8]. In primary and immortalized cellular systems, low-dose doxorubicin preserves cellular viability (yielding over 50–60% survival at 48 hours) while inducing robust centrosome abnormalities and persistent micronucleation [8][9]. Cells entering this senescent state maintain chronic, low-level cGAS-STING signaling, resulting in sustained release of IFN-β, CXCL10, and CCL5 [1][4]. In immunocompetent preclinical models, including C57BL/6 mice bearing syngeneic tumors, this STING-dependent cytokine release is mandatory for recruiting and cross-priming Batf3-dependent CD8α+ and CD103+ conventional dendritic cells (cDC1s) [1][10]. Activation of this axis reshapes the immunosuppressive tumor microenvironment, potentiating tumor-infiltrating lymphocyte (TIL) engraftment and synergizing with immune checkpoint blockade therapy [1].